Literature DB >> 21045710

Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.

Nancy J Mendelsohn1, Paul Harmatz, Olaf Bodamer, Barbara K Burton, Roberto Giugliani, Simon A Jones, Christina Lampe, Gunilla Malm, Robert D Steiner, Rossella Parini.   

Abstract

PURPOSE: To characterize surgical histories typical of patients with mucopolysaccharidosis type II, thereby broadening understanding of the natural history of these patients and helping physicians recognize the disease.
METHODS: Data on surgical interventions from the Hunter Outcome Survey--a multinational, observational database of patients with mucopolysaccharidosis type II-were analyzed. The study population comprised 527 patients for whom surgical data were reported on/before July 23, 2009.
RESULTS: Surgical interventions were performed in 83.7% of the study population. Patients underwent their first operation at a median age of 2.6 years. Tympanostomies, repairs of inguinal hernias, and operations for carpal tunnel syndrome were performed in a greater proportion of the study population than the general population. A median of 3.0 operations was performed per patient; repeat operations for hernia or carpal tunnel syndrome were common. The majority of patients (221/389) underwent at least one surgical intervention before diagnosis of mucopolysaccharidosis type II.
CONCLUSION: Patients with mucopolysaccharidosis type II typically undergo surgical intervention at a young age, often before diagnosis. Repeated early surgical interventions, particularly for hernias or carpal tunnel syndrome, are characteristic of patients with mucopolysaccharidosis type II. We recommend that such patients are carefully examined for manifestations of mucopolysaccharidosis disorders and referred for diagnostic testing.

Entities:  

Mesh:

Year:  2010        PMID: 21045710     DOI: 10.1097/GIM.0b013e3181f6e74d

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  30 in total

1.  Detection by Urinary GAG Testing of Mucopolysaccharidosis Type II in an At-Risk Spanish Population.

Authors:  Laura López-Marín; Luis G Gutiérrez-Solana; Luis Aldamiz-Echevarria Azuara; Rogelio Simón de Las Heras; Anna Duat Rodríguez; Verónica Cantarín Extremera
Journal:  JIMD Rep       Date:  2013-02-02

2.  Activity of daily living for Morquio A syndrome.

Authors:  Eriko Yasuda; Yasuyuki Suzuki; Tsutomu Shimada; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Li Xie; Freeman Miller; Tariq Rahman; Heidi H Kecskemethy; Kyoko Nagao; Thierry Morlet; Thomas H Shaffer; Yasutsugu Chinen; Hiromasa Yabe; Akemi Tanaka; Haruo Shintaku; Kenji E Orii; Koji O Orii; Robert W Mason; Adriana M Montaño; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-04-25       Impact factor: 4.797

3.  Prevalence of Mucopolysaccharidosis Types I, II, and VI in the Pediatric and Adult Population with Carpal Tunnel Syndrome (CTS). Retrospective and Prospective Analysis of Patients Treated for CTS.

Authors:  Mette Borch Nørmark; Nanna Kjaer; Allan Meldgaard Lund
Journal:  JIMD Rep       Date:  2017-01-17

4.  Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.

Authors:  Annerose Keilmann; Todsaporn Nakarat; Iain A Bruce; David Molter; Gunilla Malm
Journal:  J Inherit Metab Dis       Date:  2011-08-25       Impact factor: 4.982

5.  Successful anaesthesia management of a child with hunter syndrome for adenotonsillectomy.

Authors:  Jyotsna Punj; Paridhi Kaler; Basavaraj Ankalagi; Arya Prasad; Renu Sinha; Prem Sagar
Journal:  Intractable Rare Dis Res       Date:  2019-11

Review 6.  Anesthesia for patients with mucopolysaccharidoses: Comprehensive review of the literature with emphasis on airway management.

Authors:  Brittney M Clark; Juraj Sprung; Toby N Weingarten; Mary E Warner
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

7.  Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.

Authors:  Julian Tanjuakio; Yasuyuki Suzuki; Pravin Patel; Eriko Yasuda; Francyne Kubaski; Akemi Tanaka; Hiromasa Yabe; Robert W Mason; Adriana M Montaño; Kenji E Orii; Koji O Orii; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

8.  Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma.

Authors:  Jin Li; Xinyan Zhang; Tao Jiang; Chunde Li
Journal:  Childs Nerv Syst       Date:  2018-11-15       Impact factor: 1.475

Review 9.  Mucopolysaccharidoses.

Authors:  Rolando Cimaz; Francesco La Torre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

10.  Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls.

Authors:  Barbara K Burton; Roberto Giugliani
Journal:  Eur J Pediatr       Date:  2012-03-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.